The 2nd Annual Biomarker Conference
After an overwhelming response on our Annual Biomarker Conference, MnM Conferences is pleased to announce The 2nd Annual Biomarker Conference which will take place on the 6th and 7th of February 2017, in San Diego-CA, USA.
The recent success of companion diagnostics along with the increasing regulatory pressure for better identification of the target population has created an extraordinary spur for drug discovery companies to invest in novel strategies for biomarker discovery. Also, the confluence of immunology and oncology tributaries has triggered a biomarker turbulence that is novel to the cancer community.
The pursuit to drive precision medicine and the quest to refine a biomarker model for immuno-oncology drug development, The 2nd Annual Biomarker Conference aims to gather experts from pharma, bio-pharma companies and research institutes to discuss current challenges and opportunities in biomarker discovery, CDx, NGS, regulatory and reimbursement issues and novel technologies.
Key Highlights:
- Translational Medicine and biomarkers
- NGS and Circulating biomarkers
- Biomarkers in Immuno-Oncology
- Liquid Biopsies
- Complementary diagnostics v/s Companion diagnostics
- Adaptive trial designs
- Regulatory and Reimbursement Issues
- Patient stratification
- Novel technologies in biomarkers
- Pre-clinical biomarker to clinical biomarkers
